Pharmacodynamic considerations in the use of matrix metalloproteinase inhibitors in cancer treatment

JS Yang, CW Lin, SC Su, SF Yang - Expert opinion on drug …, 2016 - Taylor & Francis
Abstract Introduction: Matrix metalloproteinases (MMPs) are classified in the family of zinc-
dependent endopeptidases, which can degrade various components of an extracellular …
被引用次数：57 相关文章
[PDF] researchgate.net

[PDF][PDF] Pharmacodynamic considerations in the use of matrix metalloproteinase inhibitors in cancer treatment

JS Yang, CW Lin, SC Su, SF Yang - EXPERT OPINION ON DRUG …, 2016 - researchgate.net
ABSTRACT Introduction: Matrix metalloproteinases (MMPs) are classified in the family of
zinc-dependent endopeptidases, which can degrade various components of an extracellular …

Pharmacodynamic considerations in the use of matrix metalloproteinase inhibitors in cancer treatment

JS Yang, CW Lin, SC Su… - Expert opinion on drug …, 2016 - pubmed.ncbi.nlm.nih.gov
Introduction Matrix metalloproteinases (MMPs) are classified in the family of zinc-dependent
endopeptidases, which can degrade various components of an extracellular matrix and a …

Pharmacodynamic considerations in the use of matrix metalloproteinase inhibitors in cancer treatment.

Y JS, L CW, S SC, Y SF - Expert Opin Drug Metab Toxicol. 2016, 2016 - ir.csmu.edu.tw
INTRODUCTION: Matrix metalloproteinases (MMPs) are classified in the family of zinc-
dependent endopeptidases, which can degrade various components of an extracellular …

Pharmacodynamic considerations in the use of matrix metalloproteinase inhibitors in cancer treatment.

JS Yang, CW Lin, SC Su, SF Yang - Expert Opinion on Drug …, 2016 - europepmc.org
Matrix metalloproteinases (MMPs) are classified in the family of zinc-dependent
endopeptidases, which can degrade various components of an extracellular matrix and a …